Drug systems approach to hypertension.
D002216:Captopril / Q000009:adverse effects / Q000494:pharmacology; D003000:Clonidine / Q000008:administration & dosage; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D006145:Guanethidine / Q000008:administration & dosage; D006801:Humans; D006830:Hydralazine / Q000008:administration & dosage; D006852:Hydrochlorothiazide / Q000008:administration & dosage; D006973:Hypertension / Q000188:drug therapy*; D006974:Hypertension, Malignant / Q000188:drug therapy; D008750:Methyldopa / Q000008:administration & dosage; D010349:Patient Compliance; D011224:Prazosin / Q000008:administration & dosage; D011507:Proteinuria / Q000139:chemically induced; D012084:Renin-Angiotensin System / Q000187:drug effects; D012110:Reserpine / Q000008:administration & dosage; D013148:Spironolactone / Q000008:administration & dosage
D004338:Drug Combinations; D006852:Hydrochlorothiazide; D006830:Hydralazine; D013148:Spironolactone; D008750:Methyldopa; D012110:Reserpine; D002216:Captopril; D003000:Clonidine; D011224:Prazosin; D006145:Guanethidine